GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Earnings Yield (Joel Greenblatt) %

Corix Bioscience (Corix Bioscience) Earnings Yield (Joel Greenblatt) % : -22.57% (As of Sep. 2017)


View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Earnings Yield (Joel Greenblatt) %?

Corix Bioscience's Enterprise Value for the quarter that ended in Sep. 2017 was $23.03 Mil. Corix Bioscience's EBIT for the trailing twelve months (TTM) ended in Sep. 2017 was $-4.94 Mil. Corix Bioscience's Earnings Yield (Joel Greenblatt) for the quarter that ended in Sep. 2017 was -22.57%.

The historical rank and industry rank for Corix Bioscience's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

CXBS's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.335
* Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Corix Bioscience's Forward Rate of Return (Yacktman) % for the quarter that ended in Sep. 2017 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Corix Bioscience Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Corix Bioscience's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Earnings Yield (Joel Greenblatt) % Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial - -72.46 -0.91 -0.25 -28.99

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.89 -28.99 -33.00 -26.18 -22.57

Competitive Comparison of Corix Bioscience's Earnings Yield (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corix Bioscience's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's Earnings Yield (Joel Greenblatt) % falls into.



Corix Bioscience Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Corix Biosciences Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2016 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-4.045/15.8641107
=-25.50 %

Corix Bioscience's EBIT for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.94 Mil.



Corix Bioscience  (GREY:CXBS) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Corix Bioscience Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Corix Bioscience (Corix Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines